Association of Clinical Trials Organizations (ACTO) –
non-commercial organization of the companies/ legal entities and clinical research community engaged in clinical trials in Russia.
December, 15 2016
Annual General Meeting of Association of Clinical Trials Organizations (ACTO) was held
The Executive Director of the Association Svetlana Zavidova made a presentation on the current situation in the Russian market of clinical trials and ACTO action strategy under the present circumstances. The meeting participants approved of ACTO Annual Report 2016.
The General Meeting admitted to membership Chiltern International LLC.
The election of the Board members took place. Leonid Dzivinsky (PRA), Maria Nassonova (Almedis), Peter Kosminsky (Janssen), Natalia Savitskaya (Eli Lilly), Anna Filimonova (Parexel), Marina Filippova (PSI) and Svetlana Zavidova (by virtue of her position) were elected for 2017.
Marina Filippova (PSI) made a presentation on the selected issues of the implåmentation of the Order No.200n of the Ministry of Health of RF dated April 01, 2016.
Maria Nassonova (Almedis) told about ACTO participation in a seminar for local ethics committees held on 11-12 November, 2016 on the basis of MSMSU named after A.I. Evdokimov. Meeting participants discussed the role of the LECs in the current conditions as well as their approaches to the collection and analysis of information on the safety.